http://biz.yahoo.com/ic/news/516.htmlThe latest news on the Diagnostic Substances industry from Yahoo! Financeen-usFri, 3 Jul 2009 04:01:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090703/20090702005813.html?.v=1TARRYTOWN, N.Y.----Regulatory News:yahoo_finance/2965337073Fri, 3 Jul 2009 04:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090702/0515995.html?.v=1yahoo_finance/2617012212Thu, 2 Jul 2009 18:21:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090702/0515818.html?.v=1yahoo_finance/4013217756Thu, 2 Jul 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090702/ne41205.html?.v=1Interleukin Genetics, Inc. announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to Pep Products, Inc., a subsidiary of Nutraceutical Corporation, for approximately $4.6 million in cash.yahoo_finance/3261490146Thu, 2 Jul 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/090701/21738.html?.v=1yahoo_finance/3485660394Wed, 1 Jul 2009 20:48:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090701/168222.html?.v=1yahoo_finance/342895430Wed, 1 Jul 2009 20:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=1282r91r1/*http%3A//boston.bizjournals.com/boston/stories/2009/06/29/daily46.html?ana=yfcpcyahoo_finance/3962710064Wed, 1 Jul 2009 19:05:25 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vc47ubk/*http%3A//online.barrons.com/article/SB124640171677476135.html?ru=yahoo#mod=yahoobarronsMyriad Problems for Myriad Genetics Shares fell sharply after the diagnostic testing company announced disappointing quarterly results. The prognosis for investors? Not good.yahoo_finance/172162345Wed, 1 Jul 2009 17:09:54 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_amag_pharmaceuticals_mover.html?.v=1Shares of AMAG Pharmaceuticals Inc. rose Wednesday after the Food and Drug Administration approved its iron replacement therapy.yahoo_finance/2544922004Wed, 1 Jul 2009 15:58:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090701/20090701005873.html?.v=1SAN DIEGO----LifeVantage Corporation , maker of Protandim®, held its inaugural ribbon cutting event June 26 and June 27 in San Diego, California, at the Hilton San Diego Bayfront Hotel.yahoo_finance/1291436414Wed, 1 Jul 2009 15:49:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/cnbc/rss/SIG=113mb0hsu/*http%3A//www.cnbc.com/id/15840232?play=1&video=1169459211&__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&par=yahooyahoo_finance/3277539718Wed, 1 Jul 2009 15:42:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_labcorp_monogram_tender_offer.html?.v=1Laboratory Corp. of America Holdings said Wednesday it started a tender offer for Monogram Biosciences Inc., a molecular diagnostics company LabCorp agreed to buy on June 23.yahoo_finance/3020175271Wed, 1 Jul 2009 14:23:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_myriad_genetics_ahead_of_the_bell.html?.v=1Shares of Myriad Genetics Inc. plunged in premarket trading Wednesday after the company forecast disappointing revenue from its molecular diagnostics business, which provides almost all its revenue.yahoo_finance/1793260386Wed, 1 Jul 2009 13:20:40 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b8BDC0826-362F-404E-A168-AB9F7017EC13%7d&siteid=yhoof2yahoo_finance/1374548539Wed, 1 Jul 2009 12:58:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090701/20090701005522.html?.v=1BURLINGTON, N.C.----Laboratory Corporation of America® Holdings today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Monogram Biosciences, Inc. for $4.55 per share.yahoo_finance/249160137Wed, 1 Jul 2009 12:26:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090701/0515477.html?.v=1yahoo_finance/2698928610Wed, 1 Jul 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_amag_pharma_feraheme.html?.v=1The Food and Drug Administration approved AMAG Pharmaceuticals Inc.'s Feraheme, an iron replacement therapy for patients with chronic kidney disease, the company said.yahoo_finance/335334489Wed, 1 Jul 2009 10:46:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11rgjl3gl/*http%3A//online.wsj.com/article/SB124639948472275961.html?ru=yahoo#mod=yahoo_hsyahoo_finance/778955618Tue, 30 Jun 2009 22:13:54 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12n5o589c/*http%3A//www.thestreet.com/_yahoo/story/10531887/1/fda-approves-amag-anemia-drug.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1006194497Tue, 30 Jun 2009 21:22:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090630/us_myriad_genetics_outlook.html?.v=1Biotechnology company Myriad Genetics Inc. said it expects to report that its fiscal 2009 molecular diagnostics revenue fell below prior guidance, citing the recession's continued pressure on consumers' ability to pay for health care.yahoo_finance/4189717787Tue, 30 Jun 2009 20:48:20 Etc/GMT